PLS and shape-based similarity analysis of maleimides – GSK-3 inhibitors

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Enzyme Inhibition and Medicinal Chemistry

• Publication date

  2014-07-14

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.3109/14756366.2013.833196PMID 24047148
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• R: A language and environment for statistical computing.

  2014cited by this paper
• Pressure-controlled motion of single polymers through solid-state nanopores.

  2013cited by this paper
• Identification of a Maleimide-Based Glycogen Synthase Kinase-3 (GSK-3) Inhibitor, BIP-135, that Prolongs the Median Survival Time of Δ7 SMA KO Mouse Model of Spinal Muscular Atrophy.

  2012cited by this paper
• Conformer Generation with OMEGA: Learning from the Data Set and the Analysis of Failures

  2012cited by this paper
• QSAR modeling and data mining link Torsades de Pointes risk to the interplay of extent of metabolism, active transport, and HERG liability.

  2012cited by this paper
• In silico classification and virtual screening of maleimide derivatives using projection to latent structures discriminant analysis (PLS-DA) and hybrid docking

  2012cited by this paper
• Computational Drug Design – A Guide for Computational and Medicinal Chemists

  2011cited by this paper
• PubChem3D: Shape compatibility filtering using molecular shape quadrupoles

  2011cited by this paper
• Investigating the correlations among the chemical structures, bioactivity profiles and molecular targets of small molecules

  2010cited by this paper
• Quo vadis, virtual screening? A comprehensive survey of prospective applications.

  2010cited by this paper
• QSAR study of carboxylic acid derivatives as HIV-1 Integrase inhibitors.

  2010cited by this paper
• Novel 8-arylated purines as inhibitors of glycogen synthase kinase.

  2010cited by this paper
• Conformer Generation with OMEGA: Algorithm and Validation Using High Quality Structures from the Protein Databank and Cambridge Structural Database

  2010cited by this paper
• A modeling analysis of the effects of molecular size and binding affinity on tumor targeting

  2009cited by this paper
• Glycogen synthase kinase-3 inhibition by 3-anilino-4-phenylmaleimides: insights from 3D-QSAR and docking

  2009cited by this paper
• Multitemplate Alignment Method for the Development of a Reliable 3D-QSAR Model for the Analysis of MMP3 Inhibitors

  2009cited by this paper
• Novel Approach to Structure-Based Pharmacophore Search Using Computational Geometry and Shape Matching Techniques

  2008cited by this paper
• The ade4 Package: Implementing the Duality Diagram for Ecologists

  2007cited by this paper
• Changes in Osteoblast, Chondrocyte, and Adipocyte Lineages Mediate the Bone Anabolic Actions of PTH and Small Molecule GSK‐3 Inhibitor

  2007cited by this paper
• 3D-QSAR and molecular docking study on bisarylmaleimide series as glycogen synthase kinase 3, cyclin dependent kinase 2 and cyclin dependent kinase 4 inhibitors: an insight into the criteria for selectivity.

  2007cited by this paper
• Predictive QSAR modeling workflow, model applicability domains, and virtual screening.

  2007cited by this paper
• Comparison of shape-matching and docking as virtual screening tools.

  2007cited by this paper
• Lessons in Molecular Recognition, 2. Assessing and Improving Cross-Docking Accuracy

  2007cited by this paper
• On Evaluating Molecular-Docking Methods for Pose Prediction and Enrichment Factors

  2006cited by this paper
• 2D Autocorrelation Modelling of the Inhibitory Activity of Cytokinin-Derived Cyclin-Dependent Kinase Inhibitors

  2006cited by this paper
• QSAR modeling of the inhibition of glycogen synthase kinase-3.

  2006cited by this paper
• Geometric Accuracy of Three-Dimensional Molecular Overlays

  2006cited by this paper
• Probing the physicochemical and structural requirements for glycogen synthase kinase-3alpha inhibition: 2D-QSAR for 3-anilino-4-phenylmaleimides.

  2006cited by this paper
• A shape-based 3-D scaffold hopping method and its application to a bacterial protein-protein interaction.

  2005cited by this paper
• A small molecule–kinase interaction map for clinical kinase inhibitors

  2005influential reference
• 3D-QSAR and Docking Studies of Selective GSK-3beta Inhibitors. Comparison with a Thieno[2, 3-b]pyrrolizinone Derivative, a New Potential Lead for GSK-3beta Ligands

  2005cited by this paper
• The development of potent and selective bisarylmaleimide GSK3 inhibitors.

  2005cited by this paper
• Predictive QSAR modeling based on diversity sampling of experimental datasets for the training and test set selection

  2004cited by this paper
• 1-Azakenpaullone is a selective inhibitor of glycogen synthase kinase-3 beta.

  2004cited by this paper
• GSK3 inhibitors: development and therapeutic potential

  2004cited by this paper
• Structural basis for the synthesis of indirubins as potent and selective inhibitors of glycogen synthase kinase-3 and cyclin-dependent kinases.

  2004cited by this paper
• Conformational analysis of drug-like molecules bound to proteins: an extensive study of ligand reorganization upon binding.

  2004cited by this paper
• Time-resolved QSAR: an approach to PLS modelling of three-way biological data

  2004cited by this paper
• 1‐Azakenpaullone Is a Selective Inhibitor of Glycogen Synthase Kinase‐3β.

  2004cited by this paper
• Rational selection of training and test sets for the development of validated QSAR models

  2003cited by this paper
• Assessing the performance of OMEGA with respect to retrieving bioactive conformations.

  2003cited by this paper
• Quantitative structure‐property relationships for prediction of boiling point, vapor pressure, and melting point

  2003cited by this paper
• Glycogen synthase kinase-3 as drug target: from wallflower to center of attention.

  2003cited by this paper
• The Importance of Being Earnest: Validation is the Absolute Essential for Successful Application and Interpretation of QSPR Models

  2003cited by this paper
• GSK-3: tricks of the trade for a multi-tasking kinase

  2003influential reference
• Beware of q2!

  2002cited by this paper
• Predictive QSAR modeling based on diversity sampling of experimental datasets for the training and test set selection

  2002cited by this paper
• Multi‐ and Megavariate Data Analysis. Principles and Applications, I. Eriksson, E. Johansson, N. Kettaneh‐Wold and S. Wold, Umetrics Academy, Umeå, 2001, ISBN 91‐973730‐1‐X, 533pp.

  2002cited by this paper
• GSK‐3 inhibition by adenoviral FRAT1 overexpression is neuroprotective and induces Tau dephosphorylation and β‐catenin stabilisation without elevation of glycogen synthase activity

  2001cited by this paper
• Selective small‐molecule inhibitors of glycogen synthase kinase‐3 activity protect primary neurones from death

  2001cited by this paper
• GSK3 takes centre stage more than 20 years after its discovery.

  2001cited by this paper
• Selective small-molecule inhibitors of glycogen synthase kinase-3 activity protect primary neurones from death.

  2001cited by this paper
• 3-Anilino-4-arylmaleimides: potent and selective inhibitors of glycogen synthase kinase-3 (GSK-3).

  2001cited by this paper
• Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription.

  2000cited by this paper
• Flexibility, Conformation Spaces, and Bioactivity

  2000cited by this paper
• Glycogen synthase kinase 3 is an insulin-regulated C/EBPalpha kinase.

  1999cited by this paper
• Glycogen Synthase Kinase 3 Is an Insulin-Regulated C/EBPα Kinase

  1999cited by this paper
• 3D QSAR: current state, scope, and limitations

  1998cited by this paper
• Regulation of eukaryotic initiation factor eIF2B: glycogen synthase kinase‐3 phosphorylates a conserved serine which undergoes dephosphorylation in response to insulin

  1998cited by this paper
• Lithium Reduces Tau Phosphorylation by Inhibition of Glycogen Synthase Kinase-3*

  1997cited by this paper
• Correlation of Boiling Points with Molecular Structure. 1. A Training Set of 298 Diverse Organics and a Test Set of 9 Simple Inorganics

  1996cited by this paper
• The Coding of the Three-Dimensional Structure of Molecules by Molecular Transforms and Its Application to Structure-Spectra Correlations and Studies of Biological Activity

  1996cited by this paper
• Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

  1995cited by this paper
• Charge Indexes. New Topological Descriptors

  1994cited by this paper
• PLS: Partial Least Squares Projections to Latent Structures

  1993cited by this paper
• Glycogen synthase kinase 3 phosphorylates Jun family members in vitro and negatively regulates their transactivating potential in intact cells.

  1993cited by this paper
• Molecular Connectivity in Structure–activity Analysis

  1987cited by this paper
• Inclusion of Symmetry as a Shape Attribute in Kappa Index Analysis

  1987cited by this paper
• Chemical applications of topology and group theory

  1985cited by this paper
• Chemical Applications of Topology and Graph Theory, R.B. King (Ed.). Elsevier Science Publishers, Amsterdam (1983), (ISBN 0-444-42244-7). XII + 494 p. Price Dfl. 275.00

  1985cited by this paper
• Development and use of quantum mechanical molecular models. 76. AM1: a new general purpose quantum mechanical molecular model

  1985cited by this paper
• The detection of disease clustering and a generalized regression approach.

  1967cited by this paper
• A NEW MEASURE OF RANK CORRELATION

  1938cited by this paper
• LIII. On lines and planes of closest fit to systems of points in space

  1901cited by this paper
• General Intelligence, Objectively Determined and Measured.

  year unknowncited by this paper
• Introduction General Considerations

  year unknowncited by this paper
• Mathematical Contributions to the Theory of Evolution. III. Regression, Heredity, and Panmixia

  year unknowncited by this paper

• A Hybrid Machine Learning Pipeline for Reliable Prediction of Potential HIV-1 Inhibitors

  2025cites this paper
• A Comprehensive Environmental and Molecular Strategy for the Evaluation of Fluroxypyr and Nature-Derived Compounds

  2025cites this paper
• In silico approach for fighting human immunodeficiency virus: a drug repurposing strategy

  2024cites this paper
• New Insights on the Activity and Selectivity of MAO-B Inhibitors through In Silico Methods

  2023cites this paper
• Natural Compounds as DPP-4 Inhibitors: 3D-Similarity Search, ADME Toxicity, and Molecular Docking Approaches

  2022cites this paper
• Small Molecules of Natural Origin as Potential Anti-HIV Agents: A Computational Approach

  2021cites this paper
• Comprehensive investigation of selectivity landscape of glycogen synthase kinase-3 inhibitors

  2020cites this paper
• Portraying the selectivity of GSK-3 inhibitors towards CDK-2 by 3D similarity and molecular docking

  2018cites this paper
• Recent Advances in Computational Approaches for Designing Potential Anti-Alzheimer’s Agents

  2018cites this paper
• Discovery of Fungal Denitrification Inhibitors by Targeting Copper Nitrite Reductase from Fusarium oxysporum

  2017cites this paper
• Application of Shape Similarity in Pose Selection and Virtual Screening in CSARdock2014 Exercise

  2016cites this paper
• QSAR studies in the discovery of novel type-II diabetic therapies

  2016cites this paper